Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193743-25-000003
Filing Date
2025-02-26
Accepted
2025-02-26 17:23:07
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1422
  Complete submission text file 0001193743-25-000003.txt   3044
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AIM IMMUNOTECH INC. 2117 SW HIGHWAY 484 OCALA FL 34473
Business Address
CHEMEROW DAVID I. (Reporting) CIK: 0001193743 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-27072 | Film No.: 25671508